Summary
Steatohepatitis has recently been increasing as a cofactor influencing the progression of fibrosis, cirrhosis, adenoma and carcinoma in liver; however, the mechanisms by which it contributes to liver injury remain uncertain. We induced steatohepatitis in zebrafish embryos using thioacetamide (TAA). TUNEL assay revealed significant increasing of apoptosis in liver after 5 days post fertilization and the increasing of apoptosis was observed to be associated with the up-regulation of apoptotic genes such as, bad, bax, P-38a, caspase-3 and 8, and JNK-1. Histological sections by oil red O stain showed the accumulation of fatty droplets which causes the pushing of the nucleus towards one side. Up-regulation of steatosis markers such as, ACC, adiponectin, PTL, CEBP- \(\alpha\) and \(\beta\), SREBP-1 was also observed. Furthermore, the elevation of glutathione peroxidase in TAA treated embryos indicated that TAA induces lipid peroxidation which leads to causes liver damage. Zebrafish has already been considered as a good human disease model and in this context; TAA-treated zebrafish may serve as a good animal model to study the molecular pathogenesis of steatohepatitis. Moreover, non-availability of specific drugs to prevent steatohepatitis, this animal model may serve as a powerful preclinical platform to study the therapeutic strategies and for evaluating chemoprevention strategies for this disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Reid A.E. (2001). Nonalcoholic steatohepatitis. Gastroenterology. 121:710–723
Ledda-Columbano G.M., Coni P., Curto M., Giacomini L., Faa G., Oliverio S., Piacentini M., Columbano A. (1991). Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am. J. Pathol. 139:1099–1109
Muller D., Zimmerman S.I., Schiller F. (1982). Drug metabolism in rat liver injured by thioacetamide. Arch. Toxicol. 5:368–371
Cruz A., Padillo F.J., Torres E., Navarrete C.M., Munoz-Castaneda J.R., Caballero F.J., Briceno J., Marchal T., Tunez I., Montilla P., Pera C., Muntane J. (2005). Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J. Pineal Res. 39:143–150
Kuriyama S., Tsujimoto T., Nakatani Y., Tsujinoue H., Yoshiji H., Mitoro A., Yamazaki M., Okuda H., Toyokawa Y., Nagao S., Nishiwaki I., Fukui H. (1999). Sonographic estimation of liver tumor development induced by oral administration of thioacetamide in rat. In Vivo. 3:129–134
Al-Bader A.A., Mathew T.C., Al-Mosawi M., Dashti H.M., Kumar D., Singal P.K. (2003). Thioacetamide induced changes in trace elements and kidney damage. J. Trace Elem. Exp. Med. 12:1–14
Dashti H., Jeppsson B., Hagerstrand I., Hultberg B., Srinivas U., Abdulla M., Joelsson B., Bengmark S. (1987). Early biochemical and histological changes in rats exposed to a single injection of thioacetamide. Pharmacol. Toxicol. 60:171–174
Gallagher C.H., Gupta D.N., Judah J.D., Rees K.R. (1956). Biochemical changes in liver in acute thioacetamide intoxication. J. Pathol. Bacteriol. 72:193–201
Dashti H.M., Mathew T.C., Jadaon M.M., Ashkanani E. (1997). Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition 13:206–212
Lee J.W., Shin K.D., Lee M., Kim E.J., Han S.S., Han M.Y., Ha H., Jeong T.C., Koh W.S. (2003). Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression. Toxicol. Lett. 136:163–172
Barker E.A., Smuckler E.A. (1972). Altered microsome function during acute thioacetamide poisoning. Mol. Pharmacol. 8:318–326
Morley C.G., Boyer J.L. (1977). Stimulation of hepatocellular proliferation by a serum factor from thioacetamide-treated rats. Biochim. Biophys. Acta 477:165–176
Her G.M., Chiang C.C., Chen W.Y., Wu J.L. (2003). In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett. 538:125–133
Her G.M., Yeh Y.H., Wu J.L. (2003). 435-bp liver regulatory sequence in the liver fatty acid binding protein (L-FABP) gene is sufficient to modulate liver regional expression in transgenic zebrafish. Dev. Dyn. 227:347–356
Westerfield M. (1994). The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio). 2nd ed. University of Oregon Press, Eugene
Ramaiah S.K., Apte U., Mehendale H.M. (2001). Cytochrome P4502E1 induction increases thioacetamide liver injury in dietrestricted rats. Drug Metab. Dispos. 29:1088–1095
Hunter A.L., Holscher M.A., Neal R.A. (1977). Thioactamide induced hepatic necrosis. Involvement of the mixed function oxidase enzyme system. J. Pharmacol. Exp. Ther. 200:439–448
Witzma F.A., Fultz C.D., Mangipudy R.S., Mehendale H.M. (1996). Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats. Fundam. Appl. Toxicol. 31:124–132
Martin H., Sarsat J.P., deWaziers I., Housset C., Balladur P., Beaune P., Albaladejo V., Lerche-Langrand C. (2003). Induction of cytochrome P450 2B6 and 3A4 expression by Phenobarbital and cyclophosphamide in cultured human liver slices. Pharm. Res. 20:557–568
Meredith C., Scott M.P., Renwick A.B., Price RJ, Lake BG. (2003). Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica 33:511–527
Chieli E., Malvadi G. (1985). Role of Cyt P-450 dependent and FAA containing mono oxygenases in the bioactivation of thioacetamide, thiobezamide and their sulophoxides. Biochem. Pharmacol. 34:395–396
Ambrose A.M., DeEds F., Rather L.J. (1949). Toxicity of thioacetamide in rats. J. Indian Hygiene Toxicol. 31:158–161
Neal R.A., Halpert J. (1982). Toxicology of thionosulfer compounds. Annu. Rev. Pharmacol. Toxicol. 22:321–339
Unger R.H., Orci L. (2002). Lipoapoptosis: its mechanism and its diseases. Biochim. Biophy. Acta. 1585:202–212
Marchesini G., Brizi M., Morselli-Labate A.M., et al. (1999). Association of non lcoholic fatty liver disease with insulin resistance. Am. J. Med. 107:450–455
Shimomura I., Bashmakov Y., Ikemoto S., Horton J.D., Brown M.S., Goldstein J.L., (1999). Insulin selectively increases SREBP-1c mRNA in the livers of rats with treptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96:13656–13661
Foretz M., Guichard C., Ferre P., Foufelle F. (1999). Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA. 96:12737–12742
Horton J.D., Goldstein J.L., Brown M.S. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109:1125–1131
Robertson G.., Leclercq I., Farrell G.C. (2001). Nonalcoholic steatosis and steatohepatitis: II Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 281:1135–1139
Davila J.C., Lenherr A., Acosta D. (1989). Protective effects of flavonoids on drug induced hepatotoxicity. Toxicology 57:267–268
Reddy J.K., Hashimoto T. (2001). Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21:193–230
Gonzalez F.J., Peters J.M., Carttley R.C. (1998). Mechanism of action of the nongenotoxic peroxysome proliferators activator receptor alpha. J. Natl. cancer Inst. 90:1702–1709
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amali, A.A., Rekha, R.D., Lin, C.JF. et al. Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis. J Biomed Sci 13, 225–232 (2006). https://doi.org/10.1007/s11373-005-9055-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11373-005-9055-5